Our latest news
Investor event with a focus on opportunities within life science
NEWS. On November 9, 2023, Sciety invited its investor network to an exclusive event on the theme of future scenarios and opportunities within life science. The evening featured a panel discussion on data-driven precision medicine with Tommi Unkuri, Partner and…
Read moreSciety’s portfolio company Neogap raises SEK 83 million
PRESS RELEASE. Sciety och Sciety Venture Partners have invested SEK 54 million in Neogap Therapeutics (Neogap), a Swedish clinical-stage biotech company that develops personalised immunotherapy for cancer treatment with the help of two emerging technologies. The company has also been…
Read moreAre you searching for the next big thing in life science and health tech?
Your search ends here. By joining Sciety Venture Partners, you have the opportunity to invest alongside Sciety in the most promising life science companies. Not only do you benefit from our extensive research and expertise, but you also become part of a network of like-minded investors.
Let us make health and life science innovations reach their full potential. Sign up to join Sciety Venture Partners and start receiving invitations to investor events, investment opportunities and news.
Lots of opportunities, lots to be done
Sweden takes the lead
Sweden is Northern Europe's most dynamic market for life sciences, with a strong focus on innovation and collaboration. It is in the top five among the world's countries in terms of investment in research and development.
Long-term demand
An aging population, increasing incidence of lifestyle diseases, and more demanding health care consumers are increasing demand for drugs, innovative medical technology, and digital solutions.
Precision medicine and genomics
The biotechnological revolution creates new opportunities to develop customized treatments for each individual disease case. This in turn leads to increased demand for precision diagnostics and technology solutions in areas such as genomics.
Growth companies on top
Growth companies in the biopharma sector are behind the majority of all new drugs approved by the FDA. Increasing numbers of partnership agreements are also being signed between Big Pharma and smaller companies.
More tech in healthcare
Digital solutions are being implemented at a fast pace. Efforts to streamline healthcare processes, cost savings, and improved health care quality as well as increased demand for on-demand care are drivers behind this trend.
Life saving advancements
Over the past 100 years, the global average life expectancy has more than doubled and is now 73 years. The child mortality rate in the world has declined by nearly 75% since 1950. Significant medical advances are one of the causes behind this positive development.
Are you looking for an investor that will support you in turning your life science or health tech innovation into a thriving business?
We got you covered.
At Sciety, we understand that securing an investment is just the first step in building a successful company. That is why our investment is more than just financial capital – it is a long-term partnership.
Our team of experts, including researchers, clinicians, entrepreneurs, and business professionals, brings a unique combination of skills to the table. We are dedicated to helping you reach your full potential and will be by your side every step of the way. Want to learn more?
Companies we are investing in right now
We are out there looking for the next big thing or at the office analyzing, verifying the facts, drafting agreements. Sign up and we will let you know once have got something great.
Some of our portfolio companies
Pharmnovo AB
PharmNovo is a pharmaceutical company at the clinical stage of developing a unique type of treatment for nerve pain (neuropathic pain), a condition currently lacking effective and safe treatment. The company is currently finalising its clinical phase I study and is advancing its preparations for a phase II study.
Neogap Therapeutics AB
NEOGAP Therapeutics develops a new type of personalised therapy for the treatment of cancer. The company uses proprietary machine learning algorithms and patented technology to tailor the treatment for each patient and its specific tumour cells.
Encare AB
Encare not only contributes to more cost-effective surgery but also reduces complications and saves lives through their proprietary software solution that helps hospitals implement best practice throughout the entire care chain – from diagnosis and preparation to surgery and rehabilitation.
Capitainer AB
Capitainer offers a unique platform for the self-sampling of fingertip blood and plasma based on a patented microfluidic technology. The products enable easy home sampling with high precision, delivering value across the entire care chain.